SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(Amendment No. 3)(1)
NMT Medical, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.001 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
629294 10 9
- --------------------------------------------------------------------------------
(CUSIP Number)
December 31, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|_| Rule 13d-1(b)
|_| Rule 13d-1(c)
|x| Rule 13d-1(d)
(1)The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of
the Act (however, see the Notes).
<PAGE>
- --------------------- -------------------
CUSIP No. 629294 10 9 13G Page 2 of 6 Pages
- --------------------- -------------------
- --------------------------------------------------------------------------------
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Jack Reinstein
SS# ###-##-####
- --------------------------------------------------------------------------------
(a) |_|
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(b) |_|
- --------------------------------------------------------------------------------
3. SEC USE ONLY
- --------------------------------------------------------------------------------
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
- --------------------------------------------------------------------------------
5. SOLE VOTING POWER
NUMBER OF 480,000 shares (includes 65,789 shares which
SHARES Mr. Reinstein has the right to acquire within
BENEFICIALLY 60 days after December 31, 1999)
OWNED BY
EACH REPORTING -------------------------------------------------------------
PERSON 6. SHARED VOTING POWER
WITH
0 shares
-------------------------------------------------------------
7. SOLE DISPOSITIVE POWER
480,000 shares (includes 65,789 shares which Mr. Reinstein
has the right to acquire within 60 days after
December 31, 1999)
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0 shares
- --------------------------------------------------------------------------------
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
480,000 shares (includes 65,789 shares which Mr. Reinstein has the right
to acquire within 60 days after December 31, 1999)
- --------------------------------------------------------------------------------
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES*
Not Applicable
- --------------------------------------------------------------------------------
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
4.4%
- --------------------------------------------------------------------------------
12. TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
- --------------------- -------------------
CUSIP No. 629294 10 9 13G Page 3 of 6 Pages
- --------------------- -------------------
Item 1(a) Name of Issuer:
- --------- --------------
NMT Medical, Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
- --------- -----------------------------------------------
27 Wormwood Street
Boston, MA 02210
Item 2(a) Name of Person Filing:
- --------- ---------------------
Jack Reinstein
Item 2(b) Address of Principal Business Office or, if none, Residence:
- --------- -----------------------------------------------------------
2231 Sunset Plaza Drive
Los Angeles, California 90069
Item 2(c) Citizenship:
- --------- -----------
United States of America
Item 2(d) Title of Class of Securities:
- --------- ----------------------------
Common Stock, $.001 par value per share.
Item 2(e) CUSIP Number:
- --------- -------------
629294 10 9
Item 3 Description of Person Filing:
- ------ ----------------------------
Not applicable.
Item 4 Ownership:
- ------ ----------
(a) Amount Beneficially Owned:
--------------------------
<PAGE>
- --------------------- -------------------
CUSIP No. 629294 10 9 13G Page 4 of 6 Pages
- --------------------- -------------------
480,000 shares (includes 65,789 shares which Mr. Reinstein has
the right to acquire within 60 days after December 31, 1999)
(b) Percent of Class:
-----------------
4.4%
(c) Number of shares as to which person has:
---------------------------------------
(i) sole power to vote or to direct the vote:
480,000 shares (includes 65,789 shares which Mr.
Reinstein has the right to acquire within 60 days after
December 31, 1999)
(ii) shared power to vote or to direct the vote:
0 shares
(iii) sole power to dispose or to direct the disposition of:
480,000 shares (includes 65,789 shares which Mr.
Reinstein has the right to acquire within 60 days after
December 31, 1999)
(iv) shared power to dispose or to direct the disposition of:
0 shares
Item 5 Ownership of Five Percent or Less of a Class:
- ------ ---------------------------------------------
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check
the following [X].
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
- ------ ----------------------------------------------------------------
Not applicable.
<PAGE>
- --------------------- -------------------
CUSIP No. 629294 10 9 13G Page 5 of 6 Pages
- --------------------- -------------------
Item 7 Identification and Classification of the Subsidiary Which Acquired
- ------ ------------------------------------------------------------------
the Security Being Reported on by the Parent Holding Company:
-------------------------------------------------------------
Not applicable.
Item 8 Identification and Classification of Members of the Group:
- ------ ---------------------------------------------------------
Not applicable.
Item 9 Notice of Dissolution of Group:
- ------ ------------------------------
Not applicable.
Item 10 Certification:
- ------- -------------
Not applicable.
<PAGE>
- --------------------- -------------------
CUSIP No. 629294 10 9 13G Page 6 of 6 Pages
- --------------------- -------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
/s/ Jack Reinstein
DATED: February 10, 2000 ---------------------------------
Jack Reinstein
